Status:
UNKNOWN
Evaluating High-flow Nasal Cannula Oxygen Therapy Through LUS During Weaning
Lead Sponsor:
lu xiao
Conditions:
High-flow Nasal Cannula Oxygen
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Respiratory distress after extubation is associated with increased morbidity and mortality. Its multifactorial pathophysiology causes a loss of pulmonary aeration during the weaning process, the clini...
Eligibility Criteria
Inclusion
- patients above 18, mechanically ventilated on tracheal intubation for more than 48 hours.
Exclusion
- Patients with chronic obstructive pulmonary disease (COPD) with moderate to severe (3 and 4) stage defined by a forced expiratory volume in one second (FEV) \<50% of theoretical value
- Patients with previous chronic respiratory disease
- Paraplegia with level\> T8,
- Severe ICU-acquired neuromyopathy
- Patients with tracheostomy for any reason.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03384394
Start Date
March 1 2018
End Date
July 1 2019
Last Update
February 13 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.